BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10981159)

  • 1. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.
    Liebson PR; Serry RD
    Curr Hypertens Rep; 2000 Jun; 2(3):260-70. PubMed ID: 10981159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.
    van Zwieten PA
    Cardiovasc Res; 2000 Jan; 45(1):82-91. PubMed ID: 10728317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and hypertension.
    Yildiz M; Oktay AA; Stewart MH; Milani RV; Ventura HO; Lavie CJ
    Prog Cardiovasc Dis; 2020; 63(1):10-21. PubMed ID: 31759953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early target organ damage and its reversibility: the heart.
    Rosei EA; Muiesan ML
    Clin Exp Hypertens; 2004; 26(7-8):673-87. PubMed ID: 15702622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Curr Cardiol Rep; 2004 Nov; 6(6):409-15. PubMed ID: 15485599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
    Clement DL; De Buyzere M; Duprez D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-drug therapy and reduction of left ventricular mass in hypertension.
    Gottdiener JS
    Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy.
    Mizuno R; Fujimoto S; Saito Y; Yamazaki M
    Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk?
    Braz Nogueira J
    Rev Port Cardiol; 2005; 24(7-8):1007-13. PubMed ID: 16240686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.